In a recent multicohort study30, women showed a stronger association between APOE and CSF tau levels than did men, particularly among amyloid-positive individuals, suggesting that APOE may modulate the risk of downstream neurodegeneration in a sex-specific manner, particularly in the presence of amyloidosis. This evidence concerns the gene MAPT and amyloidosis.